The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022
Medical Mycology · 2024
DOI: 10.1093/mmy/myae115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Mycology, 2024. Verfasst von Stewart Walukaga und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, HIV Infections, AIDS-Related Opportunistic Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, FIC NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Given extensive improvements in access to antiretroviral therapy (ART) over the past 12 years, the HIV and cryptococcal meningitis landscapes have dramatically changed since 2010. We sought to evaluate changes in clinical presentation and clinical outcomes of people presenting with HIV-associated cryptococcal meningitis between 2010 and 2022 in Uganda. We analyzed three prospective cohorts of HIV-infected Ugandans with cryptococcal meningitis during 2010–2012, 2013–2017, and 2018–2022. We summarized baseline demographics, clinical characteristics at presentation, and 2-week and 16-week mortality. Overall, 2022 persons had confirmed cryptococcal meningitis between 2010 and 2022. In the most recent 2018–2022 cohort, 48% presented as ART-naïve, and the median CD4 cell count was 26 cells/µl. Participants in the 2018–2022 cohort had the lowest cerebrospinal fluid (CSF) opening pressure (median 22 cmH2O) and the highest percentage with sterile CSF quantitative cultures (21%) compared with earlier cohorts (P < .001 for both), signifying a less severely ill population presenting with cryptococcal meningitis. Two-week mortality was lowest among participants with cryptococcal meningitis enrolled in a clinical trial in the 2018–2022 cohort at 13% compared to 26% in both 2010–2012 and 2013–2017 (P < .001). While AIDS-related deaths have dramatically declined over the past 12 years, cryptococcosis persists, presenting challenges to HIV program implementation. Two-week mortality has improved in the most recent cohort, likely due to the establishment of cryptococcal screening programs, better supportive care including scheduled lumbar punctures, and the availability of flucytosine—an essential component of antifungal therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
- Division of Biostatistics and Health Science Data, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
- Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
- Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
ORCID-Profile: Stewart Walukaga, Kenneth Ssebambulidde, Enock Kagimu, John Kasibante, Jane Gakuru, Ananta S Bangdiwala, Kathy Huppler Hullsiek, Radha Rajasingham
Förderung
- NIAID NIH HHS
- FIC NIH HHS
- NINDS NIH HHS
- National Institute of Neurologic Diseases
- Wellcome Trust
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Walukaga, S., Fieberg, A., Musubire, A., Tugume, L., Ssebambulidde, K., Kagimu, E., Kasibante, J., Rutakingirwa, M. K., Mpoza, E., Gakuru, J., Akampurira, A., Jjunju, S., Mwesigye, J., Muzoora, C., Nuwagira, E., Bangdiwala, A. S., Williams, D. A., Rhein, J., Meya, D. B., …, & ASTRO team (2024). The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022. Medical Mycology. https://doi.org/10.1093/mmy/myae115
Vancouver
Walukaga S, Fieberg A, Musubire A, Tugume L, Ssebambulidde K, Kagimu E, et al. The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022. Medical Mycology. 2024. doi:10.1093/mmy/myae115
BibTeX
@article{Walukaga2024,
author = {Walukaga, Stewart and Fieberg, Ann and Musubire, Abdu and Tugume, Lillian and Ssebambulidde, Kenneth and Kagimu, Enock and Kasibante, John and Rutakingirwa, Morris K and Mpoza, Edward and Gakuru, Jane and Akampurira, Andrew and Jjunju, Samuel and Mwesigye, James and Muzoora, Conrad and Nuwagira, Edwin and Bangdiwala, Ananta S and Williams, Darlisha A and Rhein, Joshua and Meya, David B and Boulware, David R and Hullsiek, Kathy Huppler and Rajasingham, Radha and ASTRO team, ASTRO team},
title = {The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022},
journal = {Medical Mycology},
year = {2024},
doi = {10.1093/mmy/myae115}
}
EUVIMED